Low cobalamin (vitamin BI2) levels in multiple myeloma: A retrospective study

Netherlands Journal of Medicine

Volumn 61, Issue 8, 2003, Pages 249-252

  Vlasveld, L Th ^a  

^a MEDICAL CENTER HAAGLANDEN   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

COBALAMIN; HEMOGLOBIN; PARAPROTEIN; CYANOCOBALAMIN;

ADULT; AGE; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GENDER; HEMATOLOGICAL PARAMETERS; HEMOGLOBIN DETERMINATION; HUMAN; MALE; MEAN CORPUSCULAR VOLUME; MULTIPLE MYELOMA; NETHERLANDS; OUTCOMES RESEARCH; PREVALENCE; RETROSPECTIVE STUDY; SCORING SYSTEM; TUMOR CLASSIFICATION; VITAMIN BLOOD LEVEL; BLOOD; CYANOCOBALAMIN DEFICIENCY; METABOLISM; MIDDLE AGED;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE MYELOMA; PREVALENCE; RETROSPECTIVE STUDIES; VITAMIN B 12; VITAMIN B 12 DEFICIENCY;

EID: 0642364982     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Croucher PI, Apperley JF. Bone disease in multiple myeloma. Br J Haematol 1998;103:902-10.
2. 12 in het serum van lijders aan multipel myeloom. Ned Tijdschr Geneeskd 1956;100:3588.
3. Hoffbrand AV, Hobbs JR, Kremenchuzky S, Mollin DL. Incidence and pathogenesis of megaloblastic erythropoiesis in multiple myeloma. J Clin Pathol 1967;20:699-705.
4. 12 metabolism in myelomatosis. Scand J Haematol 1977;18:395-402.
5. Ermens AAM, Sonneveld P, Michiels JJ, Lindemans J. Increased uptake and accumulation of cobalamin by multiple myeloma bone marrow cells as a possible cause of low serum cobalamin. Eur J Haematol 1993;50:57-9.
6. 12 deficiency. Scand J Gastroenterol 1974;9(suppl 29):85-7.
7. 12 & folate assays. Clin Chem 1993; 39:700-1.
8. Durie BG, Salmon SE. A clinical staging system for multiple myeloma. Correlation of measured myeloma cell mass with presenting clinical features, response to treatment, and survival. Cancer 1975;36:842-54.
9. Forshaw J. Megaloblastic erythropoiesis in multiple myeloma. BMJ 1963;2:101.
10. Ermens AAM, Vlasveld LTh, Marion-Kievit JA van, Lensen CJPA, Lindemans J. De betekenis van een te hoge cobalamineconcentratie in het bloed. Ned Tijdschr Geneeskd 2002;146:459-64.
11. Gimsing P, Overballe-Petersen CO, Hippe E. Cobalamin and cobalamin-binding proteins in plasma related to the clinical condition in chronic myelogenous leukemia. Leukemia 1995;9:1604-9.
12. Carmel R, Hollander D. Extreme elevation of transcobalamin II levels in multiple myeloma and other disorders. Blood 1978;51:1057-63.
13. 12 proteins in multiple myeloma. J Med 1990;21:277-86.
14. Larsson SO. Myeloma and pernicious anaemia. Acta Med Scand 1962;172:195-205.
15. Di Bisceglie AM, Hodkinson HJ. Multiple myeloma and pernicious anaemia. S Afr Med J 1982;62:535-6.
16. Perille PE. Myeloma and pernicious anemia. Am J Med Sc 1978;275:93-8.
17. 12 binding capacity in chronic myelogeneous leukemia and other disorders. Am J Med Sc 1972;263:473-80.
18. Eastell R, Vieira NE, Yergey AL, et al. Pernicious anaemia as a risk factor for osteoporosis. Clin Sc 1992;82:681-5.
19. 12 and folic acid in myelomatosis: cobalamin coenzyme and tetrahydrofolic acid function. Scand J Haematol 1978;20:360-70.
20. Carmel R, Lau W, Baylink DJ, Saxena S, Singer FR. Cobalamin and osteoblast-specific proteins. N Eng J Med 1988;319:70-5.
21. 12 and etidronate therapy in a patient with pernicious anemia. Metabolism 1994;43:468-9.
22. Goerss JB, Kim CH, Atkinson EJ, Eastell R, O'Fallon WM, Melton LJ. Risk of fractures in patients with pernicious anemia. J Bone Mineral Res 1992;7:573-9.
23. 12 on cell proliferation and cellular alkaline phosphatse activity in human bone marrow stromal osteoprogenitor cells and UMR106 osteoblastic cells. Metabolism 1996;45:1443-6.
24. Peracchi M, Bamonti Catena F, Pomati M, Franceschi M de, Scalabrino G. Human cobalamin deficiency: alterations in serum tumour necrosis factor-alpha and epidermal growth factor. Eur J Haematol 2001;67:123-7.
25. Lubec B, Fang-Kircher S, Lubec T, Blom HJ, Boers GH. Evidence for McKusick's hypothesis of deficient collagen cross-limking in patients with homocystinuria. Biochem Biophysics Acta 1996;1315:159-62.